## Core Concept
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the progressive accumulation of mature, but functionally incompetent, lymphocytes in the blood, bone marrow, and lymphoid tissues. CLL cells typically express specific surface markers, including CD5, CD19, CD20, and CD23. The disease is often diagnosed incidentally and can present with lymphocytosis, lymphadenopathy, and sometimes autoimmune phenomena.

## Why the Correct Answer is Right
The correct answer, . , is associated with CLL because CLL cells are known to express CD5 and CD23. However, without the specific details of each option provided, we can infer based on common knowledge about CLL:

- CLL cells are typically CD5 and CD23 positive.
- They usually have low levels of surface immunoglobulins and are often CD20 dim.

## Why Each Wrong Option is Incorrect
Given the lack of specific details for each option, let's discuss general incorrect features for CLL:
- **Option A:** If it mentions a feature commonly associated with CLL (like CD5 positivity), it would not be the correct answer.
- **Option B:** Similarly, if it's a characteristic feature, it wouldn't be correct.
- **Option C:** If this option describes something not typical for CLL, like high levels of surface immunoglobulins or absence of CD5, it could potentially be correct but needs specifics.
- **Option D:** This being the correct answer implies it does not fit with typical CLL features.

## Clinical Pearl / High-Yield Fact
A key point to remember is that CLL cells are characteristically **CD5+** and **CD23+**, which differentiates them from mantle cell lymphoma cells that are also CD5+ but CD23-. This distinction is crucial for diagnosis.

## Correct Answer: D.